(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-06 View latest technical analysis
10 day averaged volume of Array Biopharma is 4549780
Date | Daily Closing Price | Open | High | Low | Volume |
06 Thu Feb 2025 | 7.62 | 7.10 | 7.77 | 6.96 | 1.179 times |
05 Wed Feb 2025 | 6.82 | 7.38 | 7.59 | 6.79 | 1.063 times |
04 Tue Feb 2025 | 7.30 | 7.04 | 7.57 | 6.88 | 0.79 times |
03 Mon Feb 2025 | 7.02 | 7.15 | 7.40 | 6.99 | 0.723 times |
31 Fri Jan 2025 | 7.33 | 7.52 | 7.65 | 7.25 | 1.04 times |
30 Thu Jan 2025 | 7.47 | 7.29 | 7.50 | 7.05 | 0.858 times |
29 Wed Jan 2025 | 7.15 | 7.32 | 7.40 | 6.87 | 1.63 times |
28 Tue Jan 2025 | 6.68 | 7.07 | 7.13 | 6.50 | 0.842 times |
27 Mon Jan 2025 | 7.03 | 7.10 | 7.29 | 6.81 | 1.151 times |
24 Fri Jan 2025 | 7.09 | 6.97 | 7.18 | 6.81 | 0.857 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 7.7, for a target of 7.3 or 6.98
Share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Target | 5.15 |
Downside Target | 5.76 |
Downside Target | 6.01 |
Downside Target | 6.25 |
Downside Target | 6.50 |
Downside Target | 6.79 |
Downside Target | 7.00 |
Downside Target | 7.18 |
Downside Target | 7.30 |
Upside Target | 7.65 |
Upside Target | 7.77 |
Upside Target | 7.79 |
Intraday share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Intraday Target | 7.02 |
Downside Intraday Target | 6.41 |
Upside Intraday Target | 8 |
Upside Intraday Target | 8.37 |
Downside Intraday Target | 7.39 |
Weekly technical analysis of Array Biopharma (ARRY)
Date | Weekly Closing Price | Open | High | Low | Volume |
06 Thu Feb 2025 | 7.62 | 7.15 | 7.77 | 6.79 | 0.68 times |
31 Fri Jan 2025 | 7.33 | 7.10 | 7.65 | 6.50 | 1.163 times |
24 Fri Jan 2025 | 7.09 | 7.09 | 7.18 | 6.25 | 3.576 times |
17 Fri Jan 2025 | 7.15 | 7.22 | 7.30 | 7.00 | 0.222 times |
17 Fri Jan 2025 | 7.15 | 6.36 | 7.30 | 6.05 | 2.482 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
Date | Monthly Closing Price | Open | High | Low | Volume |
06 Thu Feb 2025 | 7.62 | 7.15 | 7.77 | 6.79 | 0.14 times |
31 Fri Jan 2025 | 7.33 | 6.15 | 7.65 | 6.05 | 1.465 times |
31 Tue Dec 2024 | 6.04 | 5.69 | 6.33 | 5.15 | 0.485 times |
26 Tue Nov 2024 | 6.66 | 6.64 | 7.79 | 5.76 | 1.439 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.16 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.16 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.